scholarly article | Q13442814 |
P2093 | author name string | Laurent S | |
Le Gall G | |||
Madelaine MF | |||
Rasschaert D | |||
Vautherot JF | |||
P2860 | cites work | Proteins of Norwalk virus | Q30414067 |
Bovine coronavirus peplomer glycoproteins: detailed antigenic analyses of S1, S2 and HE. | Q31170806 | ||
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein | Q36685153 | ||
Recombinant vaccine for canine parvovirus in dogs | Q36697229 | ||
Sequence and genomic organization of Norwalk virus | Q36771587 | ||
Viral haemorrhagic disease of rabbits: vaccination and immune response | Q36867511 | ||
Baculovirus expression vector system for production of viral vaccines. | Q37974145 | ||
Viral haemorrhagic disease in rabbits: a review | Q38289314 | ||
Expression of rotavirus VP2 produces empty corelike particles | Q40064706 | ||
Identification and characterization of the virus causing rabbit hemorrhagic disease | Q40109776 | ||
Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits | Q40110380 | ||
Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors | Q40524438 | ||
Single major polypeptide of a calicivirus: characterization by polyacrylamide gel electrophoresis and stabilization of virions by cross-linking with dimethyl suberimidate. | Q40629561 | ||
Expression of two bovine rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal antibodies directed against the expressed proteins | Q41585045 | ||
Polyhedrin initiator codon altered to AUU yields unexpected fusion protein from a baculovirus vector | Q41853113 | ||
Nucleotide sequence of the capsid protein gene of two serotypes of San Miguel sea lion virus: identification of conserved and non-conserved amino acid sequences among calicivirus capsid proteins | Q42608427 | ||
Rabbit hemorrhagic disease virus—molecular cloning and nucleotide sequencing of a calicivirus genome | Q42621310 | ||
The amino terminal sequence of VP60 from rabbit hemorrhagic disease virus supports its putative subgenomic origin | Q42622207 | ||
Monoclonal antibodies to feline calicivirus | Q43856638 | ||
Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens | Q45775183 | ||
Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles | Q45804941 | ||
High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors | Q45846787 | ||
Monoclonal antibodies to rabbit haemorrhagic disease virus and their use in the diagnosis of infection | Q45849843 | ||
Electron and immunoelectron microscopy of rabbit haemorrhagic disease virus (RHDV). | Q45850270 | ||
Genomic and subgenomic RNAs of rabbit hemorrhagic disease virus are both protein-linked and packaged into particles | Q45854467 | ||
In vitro translation of a subgenomic mRNA from purified virions of the Spanish field isolate AST/89 of rabbit hemorrhagic disease virus (RHDV). | Q45870629 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rabbit hemorrhagic disease | Q994732 |
hemorrhagic disease | Q611571 | ||
self-assembly | Q910150 | ||
P304 | page(s) | 6794-6798 | |
P577 | publication date | 1994-10-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection | |
P478 | volume | 68 |
Q31121276 | An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy |
Q90667012 | Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells |
Q33813193 | Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family |
Q44405819 | Chimeric calicivirus-like particles elicit specific immune responses in pigs. |
Q35023930 | Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells |
Q34608302 | Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine |
Q33717736 | Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice |
Q36922594 | Cryo-electron microscopy reconstructions of two types of wild rabbit hemorrhagic disease viruses characterized the structural features of Lagovirus |
Q42941878 | Early acute depletion of lymphocytes in calicivirus-infected adult rabbits. |
Q34201869 | Evaluation of an enzyme-linked immunosorbent assay with recombinant rhoptry-associated protein 1 antigen against Babesia bovis for the detection of specific antibodies in cattle |
Q33971949 | Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine |
Q33808245 | Expression and self-assembly of virus-like particles from two genotypes of marine vesiviruses and development of an ELISA for the detection of antibodies |
Q33338439 | Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine |
Q33707522 | Feline calicivirus VP2 is essential for the production of infectious virions. |
Q33639951 | Feline calicivirus capsid protein expression and capsid assembly in cultured feline cells |
Q33787204 | Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16. |
Q39876940 | Genetic map of the calicivirus rabbit hemorrhagic disease virus as deduced from in vitro translation studies |
Q37945203 | Glycosphingolipids as receptors for non-enveloped viruses |
Q33792968 | Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. |
Q40131145 | Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles |
Q28743371 | Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig |
Q35224806 | Mannosylation of virus-like particles enhances internalization by antigen presenting cells |
Q41247583 | Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease |
Q45728666 | Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein. |
Q64068324 | Other Than Noroviruses |
Q36583083 | Production, Characterization, and Epitope Mapping of Monoclonal Antibodies Against Different Subtypes of Rabbit Hemorrhagic Disease Virus (RHDV). |
Q35865836 | Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. |
Q28730482 | Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review |
Q37195802 | Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses. |
Q41498261 | Recovery of infectious rabbit hemorrhagic disease virus from rabbits after direct inoculation with in vitro-transcribed RNA. |
Q37337252 | Review of companion animal viral diseases and immunoprophylaxis |
Q36797004 | Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. |
Q45741170 | Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease. |
Q41403501 | Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus |
Q39124912 | Snow Mountain virus genome sequence and virus-like particle assembly |
Q33812653 | Subviral particle as vaccine and vaccine platform |
Q39891157 | Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs |
Q37071420 | The non-pathogenic Australian rabbit calicivirus RCV-A1 provides temporal and partial cross protection to lethal Rabbit Haemorrhagic Disease Virus infection which is not dependent on antibody titres |
Q39871753 | Two independent pathways of expression lead to self-assembly of the rabbit hemorrhagic disease virus capsid protein |
Q38112493 | Use of baculovirus expression system for generation of virus-like particles: successes and challenges |
Q62128249 | Virus-like particle-based vaccines for animal viral infections |
Q38059059 | Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development |
Q37666808 | Virus-like particles as a vaccine delivery system: myths and facts |
Q38019283 | Virus-like particles: the new frontier of vaccines for animal viral infections. |
Search more.